{"count": 6, "results": [{"_id": "20091537", "pmid": 20091537, "title": "Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility.", "journal": "Cochrane Database Syst Rev", "authors": ["Tang T", "Lord JM", "Norman RJ", "Yasmin E", "Balen AH"], "date": "2010-01-20T00:00:00Z", "doi": "10.1002/14651858.CD003053.pub4", "meta_date_publication": "2010 Jan 20", "meta_volume": "", "meta_issue": "1", "meta_pages": "CD003053", "score": 50061.37, "text_hl": "@GENE_INS @GENE_3630 @@@Insulin@@@-sensitising drugs (@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, @CHEMICAL_Rosiglitazone @CHEMICAL_MESH:D000077154 @@@rosiglitazone@@@, @CHEMICAL_Pioglitazone @CHEMICAL_MESH:D000077205 @@@pioglitazone@@@, D-chiro-inositol) for @SPECIES_9606 @@@women@@@ with @DISEASE_Polycystic_Ovary_Syndrome @DISEASE_MESH:D011085 @@@polycystic ovary syndrome@@@, @<m>DISEASE_Calloso_genital_dysplasia</m> @DISEASE_MESH:C537962 @@@oligo amenorrhoea@@@ and @DISEASE_Infertility @DISEASE_MESH:D007246 @@@subfertility@@@.", "citations": {"NLM": "Tang T, Lord JM, Norman RJ, Yasmin E, Balen AH. Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. Cochrane Database Syst Rev. 2010 Jan 20;(1):CD003053. PMID: 20091537", "BibTeX": "@article{20091537, title={Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility.}, author={Tang T and Lord JM and Norman RJ and Yasmin E and Balen AH}, journal={Cochrane Database Syst Rev}, number={1}, pages={CD003053}}"}}, {"_id": "19821299", "pmid": 19821299, "title": "Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility.", "journal": "Cochrane Database Syst Rev", "authors": ["Tang T", "Lord JM", "Norman RJ", "Yasmin E", "Balen AH"], "date": "2009-10-07T00:00:00Z", "doi": "10.1002/14651858.CD003053.pub3", "meta_date_publication": "2009 Oct 7", "meta_volume": "", "meta_issue": "4", "meta_pages": "CD003053", "score": 50060.633, "text_hl": "@GENE_INS @GENE_3630 @@@Insulin@@@-sensitising drugs (@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, @CHEMICAL_Rosiglitazone @CHEMICAL_MESH:D000077154 @@@rosiglitazone@@@, @CHEMICAL_Pioglitazone @CHEMICAL_MESH:D000077205 @@@pioglitazone@@@, D-chiro-inositol) for @SPECIES_9606 @@@women@@@ with @DISEASE_Polycystic_Ovary_Syndrome @DISEASE_MESH:D011085 @@@polycystic ovary syndrome@@@, @<m>DISEASE_Calloso_genital_dysplasia</m> @DISEASE_MESH:C537962 @@@oligo amenorrhoea@@@ and @DISEASE_Infertility @DISEASE_MESH:D007246 @@@subfertility@@@.", "citations": {"NLM": "Tang T, Lord JM, Norman RJ, Yasmin E, Balen AH. Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. Cochrane Database Syst Rev. 2009 Oct 7;(4):CD003053. PMID: 19821299", "BibTeX": "@article{19821299, title={Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility.}, author={Tang T and Lord JM and Norman RJ and Yasmin E and Balen AH}, journal={Cochrane Database Syst Rev}, number={4}, pages={CD003053}}"}}, {"_id": "22592687", "pmid": 22592687, "title": "Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility.", "journal": "Cochrane Database Syst Rev", "authors": ["Tang T", "Lord JM", "Norman RJ", "Yasmin E", "Balen AH"], "date": "2012-05-16T00:00:00Z", "doi": "10.1002/14651858.CD003053.pub5", "meta_date_publication": "2012 May 16", "meta_volume": "", "meta_issue": "5", "meta_pages": "CD003053", "score": 50060.02, "text_hl": "@GENE_INS @GENE_3630 @@@Insulin@@@-sensitising drugs (@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, @CHEMICAL_Rosiglitazone @CHEMICAL_MESH:D000077154 @@@rosiglitazone@@@, @CHEMICAL_Pioglitazone @CHEMICAL_MESH:D000077205 @@@pioglitazone@@@, D-chiro-inositol) for @SPECIES_9606 @@@women@@@ with @DISEASE_Polycystic_Ovary_Syndrome @DISEASE_MESH:D011085 @@@polycystic ovary syndrome@@@, @<m>DISEASE_Calloso_genital_dysplasia</m> @DISEASE_MESH:C537962 @@@oligo amenorrhoea@@@ and @DISEASE_Infertility @DISEASE_MESH:D007246 @@@subfertility@@@.", "citations": {"NLM": "Tang T, Lord JM, Norman RJ, Yasmin E, Balen AH. Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. Cochrane Database Syst Rev. 2012 May 16;(5):CD003053. PMID: 22592687", "BibTeX": "@article{22592687, title={Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility.}, author={Tang T and Lord JM and Norman RJ and Yasmin E and Balen AH}, journal={Cochrane Database Syst Rev}, number={5}, pages={CD003053}}"}}, {"_id": "29183107", "pmid": 29183107, "title": "Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility.", "journal": "Cochrane Database Syst Rev", "authors": ["Morley LC", "Tang T", "Yasmin E", "Norman RJ", "Balen AH"], "date": "2017-11-29T00:00:00Z", "doi": "10.1002/14651858.CD003053.pub6", "meta_date_publication": "2017 Nov 29", "meta_volume": "11", "meta_issue": "11", "meta_pages": "CD003053", "score": 50058.402, "text_hl": "@GENE_INS @GENE_3630 @@@Insulin@@@-sensitising drugs (@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, @CHEMICAL_Rosiglitazone @CHEMICAL_MESH:D000077154 @@@rosiglitazone@@@, @CHEMICAL_Pioglitazone @CHEMICAL_MESH:D000077205 @@@pioglitazone@@@, D-chiro-inositol) for @SPECIES_9606 @@@women@@@ with @DISEASE_Polycystic_Ovary_Syndrome @DISEASE_MESH:D011085 @@@polycystic ovary syndrome@@@, @<m>DISEASE_Calloso_genital_dysplasia</m> @DISEASE_MESH:C537962 @@@oligo amenorrhoea@@@ and @DISEASE_Infertility @DISEASE_MESH:D007246 @@@subfertility@@@.", "citations": {"NLM": "Morley LC, Tang T, Yasmin E, Norman RJ, Balen AH. Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility. Cochrane Database Syst Rev. 2017 Nov 29;11(11):CD003053. PMID: 29183107", "BibTeX": "@article{29183107, title={Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility.}, author={Morley LC and Tang T and Yasmin E and Norman RJ and Balen AH}, journal={Cochrane Database Syst Rev}, volume={11}, number={11}, pages={CD003053}}"}}, {"_id": "23988170", "pmid": 23988170, "title": "Evaluation of endocrine changes in women with the polycystic ovary syndrome during metformin treatment.", "journal": "Bosn J Basic Med Sci", "authors": ["Velija-Ašimi Z"], "date": "2013-08-01T00:00:00Z", "doi": "10.17305/bjbms.2013.2359", "meta_date_publication": "2013 Aug", "meta_volume": "13", "meta_issue": "3", "meta_pages": "180-5", "score": 50052.426, "text_hl": "Evaluation of endocrine changes in @SPECIES_9606 @@@women@@@ with the @DISEASE_Polycystic_Ovary_Syndrome @DISEASE_MESH:D011085 @@@polycystic ovary syndrome@@@ during @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ treatment.", "citations": {"NLM": "Velija-Ašimi Z. Evaluation of endocrine changes in women with the polycystic ovary syndrome during metformin treatment. Bosn J Basic Med Sci. 2013 Aug;13(3):180-5. PMID: 23988170", "BibTeX": "@article{23988170, title={Evaluation of endocrine changes in women with the polycystic ovary syndrome during metformin treatment.}, author={Velija-Ašimi Z}, journal={Bosn J Basic Med Sci}, volume={13}, number={3}, pages={180-5}}"}}, {"_id": "30856025", "pmid": 30856025, "title": "The comparison of fennel infusion plus dry cupping versus metformin in management of oligomenorrhoea in patients with polycystic ovary syndrome: a randomised clinical trial.", "journal": "J Obstet Gynaecol", "authors": ["Mokaberinejad R", "Rampisheh Z", "Aliasl J", "Akhtari E"], "date": "2019-07-01T00:00:00Z", "doi": "10.1080/01443615.2018.1541232", "meta_date_publication": "2019 Jul", "meta_volume": "39", "meta_issue": "5", "meta_pages": "652-658", "score": 50045.938, "text_hl": "Some common clinical manifestations of this syndrome include @DISEASE_Dysmenorrhea @DISEASE_MESH:D004412 @@@menstrual disorders@@@ such as oligomenorrhoea and @<m>DISEASE_Calloso_genital_dysplasia</m> @DISEASE_MESH:C537962 @@@amenorrhoea@@@. The recommended therapeutic interventions include oral intervention, as well as @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, which are associated with an increased risk of @DISEASE_Thromboembolism @DISEASE_MESH:D013923 @@@vascular thromboembolism@@@, digestive complications such as @DISEASE_Nausea @DISEASE_MESH:D009325 @@@nausea@@@, and @DISEASE_Dizziness @DISEASE_MESH:D004244 @@@dizziness@@@, and @DISEASE_Vitamin_B_12_Deficiency @DISEASE_MESH:D014806 @@@vitamin B12 deficiency@@@. ", "citations": {"NLM": "Mokaberinejad R, Rampisheh Z, Aliasl J, Akhtari E. The comparison of fennel infusion plus dry cupping versus metformin in management of oligomenorrhoea in patients with polycystic ovary syndrome: a randomised clinical trial. J Obstet Gynaecol. 2019 Jul;39(5):652-658. PMID: 30856025", "BibTeX": "@article{30856025, title={The comparison of fennel infusion plus dry cupping versus metformin in management of oligomenorrhoea in patients with polycystic ovary syndrome: a randomised clinical trial.}, author={Mokaberinejad R and Rampisheh Z and Aliasl J and Akhtari E}, journal={J Obstet Gynaecol}, volume={39}, number={5}, pages={652-658}}"}}]}